Haleon is spun off from GSK Consumer Healthcare
WARREN, N.J. — Haleon has been launched as an independent consumer health company following its spin-off from GSK. Trading of shares in the newly listed business began July 18 on the London Stock Exchange, where CEO Brian McNamara presided over the day’s ceremonial opening. Trading on the New York Stock Exchange is set to begin